| 000 | 01575 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517023546.0 | ||
| 264 | 0 | _c20160104 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2015.3500 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Changming | |
| 245 | 0 | 0 |
_aAnti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cJul 2015 |
||
| 300 |
_a1291-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArtemisinins _xpharmacology |
| 650 | 0 | 4 | _aArtesunate |
| 650 | 0 | 4 | _aBleomycin |
| 650 | 0 | 4 |
_aCollagen Type I _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aHSP47 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSmad3 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xantagonists & inhibitors |
| 700 | 1 | _aXuan, Xiuping | |
| 700 | 1 | _aYao, Wenmin | |
| 700 | 1 | _aHuang, Guojin | |
| 700 | 1 | _aJin, Junfei | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 12 _gno. 1 _gp. 1291-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2015.3500 _zAvailable from publisher's website |
| 999 |
_c24749062 _d24749062 |
||